Controversies in the management of intracranial germ cell tumors.
The management of patients with primary intracranial germ cell tumors is evolving. There is attention to minimizing late effects of therapy and preserving curability in those patients with pure germinomas and in intensifying chemotherapy for patients with nongerminoma germ cell tumors in an attempt to prolong disease-free survival.
Allen
J C
JC
Department of Neurology, New York University, New York.
D001932:Brain Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D002648:Child; D006801:Humans; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D010870:Pineal Gland / Q000473:pathology / Q000601:surgery; D011379:Prognosis; D015996:Survival Rate